Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
Research We Fund: Extramural Discovery Science
- Discovery Boost Grants (DBG)
- Arizona (AZ) Discovery Boost Grants (DBG)
- Mission Boost Grants (MBG)
- Research Scholar Grants
- Postdoctoral Fellowships
- Clinician Scientist Development Grant (CSDG)
- ASTRO-ACS Clinician Scientist Development Grant (CSDG)
- Institutional Research Grants
- RFA: Leukemia Exploration and Prevention Grant Program (LEAP)
- RFA: ACS IMPACT - Expanding Prostate Cancer Clinical Trials in the Community
- RFA: Extramural Discovery Science Accelerator Award
- RFA: Cancer Health Equity Research Centers
- IMPACT RFA to Support Research to Reduce Prostate Cancer Mortality
- TheoryLab Collaborative (TLC) Grant
- RFA: The Role of Health Policy and Health Insurance in Improving Access to and Performance of Cancer Prevention, Early Detection, and Treatment Services
- ACS Professor Award
- Extramural Grants Department Staff Contacts
- Definition of Research Areas
- FAQs: ACS Extramural Discovery Science and Grant Application Submissions
- Extramural Priority Research Areas
- Our Grant Process
- American Cancer Society Research Events
- Peer Review Committee for DNA Mechanisms in Cancer (DMC)
- Peer Review Committee for Immunology and Blood Cell Development (IBCD)
- Peer Review Committee for RNA Mechanisms in Cancer (RMC)
- Peer Review Committee for Tumor Biochemistry and Endocrinology (TBE)
- Peer Review Committee for Cancer Cell Biology (CCB)
- Peer Review Committee for Cancer Detection and Progression (CDP)
- Peer Review Committee for Experimental Therapeutics (ET)
- Peer Review Committee for Metastasis and Microenvironment (MM)
- Peer Review Committee for Cancer Prevention and Health Promotion (CPHP)
- Peer Review Committee for Treatment, Palliative Care, and Survivorship Research
- Peer Review Committee for Etiology, Screening, and Early Detection (ESED)
- Peer Review Committee for Healthcare Outcomes, Policy, and Systems Research (HOPS)
- ACS Professor Peer Review Committee
- Peer Review Committee for Institutional Research Grants (IRG)
- Molecular Biology and Biochemistry (PF-MBB)
- Cell Biology and Immunology (PF-CBI)
- Cancer Detection and Experimental Therapeutics (PF-CDET)
- Clinical and Population Sciences (PF-CPS)
- Peer Review Committee for Mission Boost Grants
- Discovery Scientific Council
- Community Research Partner Participation on Grant Peer Review Committees
- American Cancer Society Professors
- Nobel Laureates and the American Cancer Society
Peer Review Committee for Etiology, Screening, and Early Detection (ESED)
Areas Reviewed
- Etiological studies that investigate the role of biological, genetic, environmental, and behavioral risk factors in the development and progression of cancer
- Observational studies (e.g., cohort studies case-control studies) designed to identify possible causes of cancer and study the patterns of risk in large populations
- Developing and testing strategies and tools for precision prevention, screening, and early detection, including biomarkers of risk
- Approaches to promoting adherence to cancer screening guidelines
Peer Review Committee Chairs
Chair, Todd Lucas, PhD, Michigan State University
Co-Chair, TBD